Host protective roles of type 2 immunity: Parasite killing and tissue repair, flip sides of the same coin

Seminars in Immunology

Volumn 26, Issue 4, 2014, Pages 329-340

  Allen, Judith E ^a   Sutherland, Tara E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Eosinophils; Helminths; IL 4R ; Macrophages; Th2 cells; Wound repair

Indexed keywords

AMPHIREGULIN; ANTIBODY; ARGINASE; INTERLEUKIN 25; INTERLEUKIN 33; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE;

ADAPTIVE IMMUNITY; EFFECTOR CELL; EOSINOPHIL; HELMINTH; INFLAMMATION; INNATE IMMUNITY; INNATE LYMPHOID CELL; LYMPHOID CELL; MACROPHAGE; NONHUMAN; PARASITE CONTROL; PARASITE KILLING; REVIEW; TH2 CELL; TISSUE REPAIR; ANIMAL; IMMUNOLOGY; INJURIES; MOUSE; NIPPOSTRONGYLUS; PARASITOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; STRONGYLE INFECTION; WOUND HEALING;

ANIMALS; CYTOKINES; MICE; NIPPOSTRONGYLUS; RESPIRATORY SYSTEM; STRONGYLIDA INFECTIONS; WOUND HEALING;

EID: 84922902948     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.06.003     Document Type: Review

References (159)

1. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011, 11:375-388.
2. Anthony R.M., Rutitzky L.I., Urban J.F., Stadecker M.J., Gause W.C. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007, 7:975-987.
3. Licona-Limón P., Kim L.K., Palm N.W., Flavell R.A. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013, 14:536-542.
4. Saenz S.A., Taylor B.C., Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008, 226:172-190.
5. Gause W.C., Wynn T.A., Allen J.E. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol 2013, 13:607-614.
6. Patel N., Wu W., Mishra P.K., Chen F., Millman A., Csóka B., et al. A2B adenosine receptor induces protective antihelminth Type 2 immune responses. Cell Host Microbe 2014, 15:339-350.
7. Lunderius-Andersson C., Enoksson M., Nilsson G. Mast cells respond to cell injury through the recognition of IL-33. Front Immunol 2012, 3:82.
8. Voehringer D., Shinkai K., Locksley R.M. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004, 20:267-277.
9. Tawill S., Le Goff L., Ali F., Blaxter M., Allen J.E. Both free-living and parasitic nematodes induce a characteristic Th2 response that is dependent on the presence of intact glycans. Infect Immun 2004, 72:398-407.
10. Hewitson J.P., Grainger J.R., Maizels R.M. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 2009, 167:1-11.
11. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004, 4:583-594.
12. Allen J.E., Wynn T.A. Evolution of th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 2011, 7:e1002003.
13. Wynn T.A. IL-13 effector functions. Annu Rev Immunol 2003, 21:425-456.
14. Urban J.F., Noben-Trauth N., Donaldson D.D., Madden K.B., Morris S.C., Collins M., et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998, 8:255-264.
15. Harvie M., Camberis M., Le Gros G. Development of CD4T cell dependent immunity against N. brasiliensis infection. Front Immunol 2013, 4:74.
16. Chen F., Liu Z., Wu W., Rozo C., Bowdridge S., Millman A., et al. An essential role for T(H)2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 2012, 18:260-266.
17. Marsland B., Kurrer M., Reissmann R., Harris N., Kopf M. Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages. Eur J Immunol 2008, 38:479-488.
18. Reece J.J., Siracusa M.C., Southard T.L., Brayton C.F., Urban J.F., Scott A.L. Hookworm-induced persistent changes to the immunological environment of the lung. Infect Immun 2008, 76:3511-3524.
19. Liew F.Y. IL-33: a Janus cytokine. Ann Rheum Dis 2012, 71(Suppl 2):i101-i104.
20. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
21. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K.A., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
22. Thomas G.D., Ruckerl D., Maskrey B.H., Whitfield P.D., Blaxter M.L., Allen J.E. The biology of nematode- and IL4Rα-dependent murine macrophage polarization in vivo as defined by RNA-Seq and targeted lipidomics. Blood 2012, 120:e93-e104.
23. Lüthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
24. Townsend M.J., Fallon P.G., Matthews D.J., Jolin H.E., McKenzie A.N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000, 191:1069-1076.
25. Yin H., Li X., Hu S., Liu T., Yuan B., Gu H., et al. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol Immunol 2013, 56:347-353.
26. Lopetuso L.R., Scaldaferri F., Pizarro T.T. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis. Fibrogenesis Tissue Repair 2012, 5:18.
27. McHedlidze T., Waldner M., Zopf S., Walker J., Rankin A.L., Schuchmann M., et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 2013, 39:357-371.
28. Kurowska-Stolarska M., Stolarski B., Kewin P., Murphy G., Corrigan C.J., Ying S., et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009, 183:6469-6477.
29. Humphreys N.E., Xu D., Hepworth M.R., Liew F.Y., Grencis R.K. IL-33 a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008, 180:2443-2449.
30. Hung L.-Y., Lewkowich I.P., Dawson L.A., Downey J., Yang Y., Smith D.E., et al. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci USA 2013, 110:282-287.
31. Fallon P.G., Ballantyne S.J., Mangan N.E., Barlow J.L., Dasvarma A., Hewett D.R., et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006, 203:1105-1116.
32. Price A.E., Liang H.-E., Sullivan B.M., Reinhardt R.L., Eisley C.J., Erle D.J., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 2010, 107:11489-11494.
33. Owyang A.M., Zaph C., Wilson E.H., Guild K.J., McClanahan T., Miller H.R.P., et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006, 203:843-849.
34. Angkasekwinai P., Srimanote P., Wang Y.-H., Pootong A., Sakolvaree Y., Pattanapanyasat K., et al. Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response. Infect Immun 2013, 81:3731-3741.
35. Caruso R., Sarra M., Stolfi C., Rizzo A., Fina D., Fantini M.C., et al. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 2009, 136:2270-2279.
36. Mchenga S.S.S., Wang D., Li C., Shan F., Lu C. Inhibitory effect of recombinant IL-25 on the development of dextran sulfate sodium-induced experimental colitis in mice. Cell Mol Immunol 2008, 5:425-431.
37. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 15:985-995.
38. Hams E., Armstrong M.E., Barlow J.L., Saunders S.P., Schwartz C., Cooke G., et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci USA 2014, 111:367-372.
39. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010, 11:289-293.
40. Proctor W.R., Chakraborty M., Fullerton A.M., Korrapati M.C., Ryan P.M., Semple K., et al. Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology 2014.
41. Kitic M., Wimmer I., Adzemovic M., Kögl N., Rudel A., Lassmann H., et al. Thymic stromal lymphopoietin is expressed in the intact central nervous system and upregulated in the myelin-degenerative central nervous system. Glia 2014, 62:1066-1074.
42. Ito T., Wang Y.-H., Duramad O., Hori T., Delespesse G.J., Watanabe N., et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005, 202:1213-1223.
43. Han H., Headley M.B., Xu W., Comeau M.R., Zhou B., Ziegler S.F. Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages. J Immunol 2012.
44. Taylor B.C., Zaph C., Troy A.E., Du Y., Guild K.J., Comeau M.R., et al. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J Exp Med 2009, 206:655-667.
45. Massacand J.C., Stettler R.C., Meier R., Humphreys N.E., Grencis R.K., Marsland B.J., et al. Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function. Proc Natl Acad Sci USA 2009, 106:13968-13973.
46. Ramalingam T.R., Pesce J.T., Mentink-Kane M.M., Madala S., Cheever A.W., Comeau M.R., et al. Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin. J Immunol 2009, 182:6452-6459.
47. Oh M.-H., Oh S.Y., Yu J., Myers A.C., Leonard W.J., Liu Y.-J., et al. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. J Immunol 2011, 186:7232-7242.
48. Maizels R.M., Hewitson J.P., Smith K.A. Susceptibility and immunity to helminth parasites. Curr Opin Immunol 2012, 24:459-466.
49. Walker J.A., McKenzie A.N.J. Development and function of group 2 innate lymphoid cells. Curr Opin Immunol 2013, 25:148-155.
50. Halim T.Y.F., Steer C.A., Mathä L., Gold M.J., Martinez-Gonzalez I., McNagny K.M., et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014, 40:425-435.
51. Hurst S.D., Muchamuel T., Gorman D.M., Gilbert J.M., Clifford T., Kwan S., et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002, 169:443-453.
52. Turner J.-E., Morrison P.J., Wilhelm C., Wilson M., Ahlfors H., Renauld J.-C., et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 2013, 210:2951-2965.
53. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
54. Kreider T., Anthony R.M., Urban J.F., Gause W.C. Alternatively activated macrophages in helminth infections. Curr Opin Immunol 2007, 19:448-453.
55. Bieren J.E.-V., Mosconi I., Guiet R., Piersgilli A., Volpe B., Chen F., et al. Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of macrophages. PLoS Pathog 2013, 9:e1003771.
56. Filbey K.J., Grainger J.R., Smith K.A., Boon L., Van Rooijen N., Harcus Y., et al. Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection. Immunol Cell Biol 2014, 92:436-448.
57. Rajan T.V., Ganley L., Paciorkowski N., Spencer L., Klei T.R., Shultz L.D. Brugian infections in the peritoneal cavities of laboratory mice: kinetics of infection and cellular responses. Exp Parasitol 2002, 100:235-247.
58. Allen J.E., Loke P. Divergent roles for macrophages in lymphatic filariasis. Parasite Immunol 2001, 23:345-352.
59. Bonne-Année S., Kerepesi L.A., Hess J.A., O'Connell A.E., Lok J.B., Nolan T.J., et al. Human and mouse macrophages collaborate with neutrophils to kill larval Strongyloides stercoralis. Infect Immun 2013, 81:3346-3355.
60. Anthony R.M., Urban J.F., Alem F., Hamed H.A., Rozo C.T., Boucher J.-L., et al. Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 2006, 12:955-960.
61. Zhao A., Urban J.F., Anthony R.M., Sun R., Stiltz J., Van Rooijen N., et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 2008, 135:217-225. e1.
62. Jenkins S.J., Ruckerl D., Thomas G.D., Hewitson J.P., Duncan S., Brombacher F., et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med 2013, 210:2477-2491.
63. Nair M.G., Du Y., Perrigoue J.G., Zaph C., Taylor J.J., Goldschmidt M., et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med 2009, 206:937-952.
64. Pesce J.T., Ramalingam T.R., Wilson M.S., Mentink-Kane M.M., Thompson R.W., Cheever A.W., et al. Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog 2009, 5:e1000393.
65. Notari L., Riera D.C., Sun R., Bohl J.A., McLean L.P., Madden K.B., et al. Role of macrophages in the altered epithelial function during a Type 2 immune response induced by enteric nematode infection. PLoS ONE 2014, 9:e84763.
66. Reese T.A., Liang H.-E., Tager A.M., Luster A.D., Van Rooijen N., Voehringer D., et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007, 447:92-96.
67. Mantovani A., Biswas S.K., Galdiero M.R., Sica A., Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013, 229:176-185.
68. Maarsingh H., Zaagsma J., Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 2009, 158:652-664.
69. Loke P., Gallagher I., Nair M.G., Zang X., Brombacher F., Mohrs M., et al. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 2007, 179:3926-3936.
70. Hung S.-I., Chang A.C., Kato I., Chang N-C.A. Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation. J Leukoc Biol 2002, 72:72-82.
71. Zhou Y., Peng H., Sun H., Peng X., Tang C., Gan Y., et al. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Sci Transl Med 2014, 6:240ra76-6.
72. Teng X., Li D., Champion H.C., Johns R.A. FIZZ1/RELMalpha a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ Res 2003, 92:1065-1067.
73. Wynes M.W., Frankel S.K., Riches D.W.H. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol 2004, 76:1019-1027.
74. Madsen D.H., Leonard D., Masedunskas A., Moyer A., Jürgensen H.J., Peters D.E., et al. M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J Cell Biol 2013, 202:951-966.
75. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007, 127:514-525.
76. Loke P., MacDonald A.S., Allen J.E. Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naïve CD4(+) T cells. Eur J Immunol 2000, 30:1127-1135.
77. Goerdt S., Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999, 10:137-142.
78. Rodríguez-Sosa M., Satoskar A.R., Calderón R., Gomez-Garcia L., Saavedra R., Bojalil R., et al. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect Immun 2002, 70:3656-3664.
79. Fenton M.J., Buras J.A., Donnelly R.P. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol 1992, 149:1283-1288.
80. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
81. Loke P., Nair M.G., Parkinson J., Guiliano D., Blaxter M., Allen J.E. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 2002, 3:7.
82. Herbert D.R., Hölscher C., Mohrs M., Arendse B., Schwegmann A., Radwanska M., et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004, 20:623-635.
83. Li M.O., Wan Y.Y., Sanjabi S., Robertson A-KL, Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006, 24:99-146.
84. Gronert K., Maheshwari N., Khan N., Hassan I.R., Dunn M., Laniado Schwartzman M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 2005, 280:15267-15278.
85. Kühn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 2006, 45:334-356.
86. Haben I., Hartmann W., Specht S., Hoerauf A., Roers A., Müller W., et al. T-cell-derived, but not B-cell-derived, IL-10 suppresses antigen-specific T-cell responses in Litomosoides sigmodontis-infected mice. Eur J Immunol 2013, 43:1799-1805.
87. Zigmond E., Bernshtein B., Friedlander G., Walker C.R., Yona S., Kim K.-W., et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 2014, 40:720-733.
88. Cohen H.B., Mosser D.M. Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol 2013, 94:913-919.
89. Sieweke M.H., Allen J.E. Beyond stem cells: self-renewal of differentiated macrophages. Science 2013, 342:1242974.
90. Guilliams M., De Kleer I., Henri S., Post S., Vanhoutte L., De Prijck S., et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med 2013, 210:1977-1992.
91. Zigmond E., Varol C., Farache J., Elmaliah E., Satpathy A.T., Friedlander G., et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012, 37:1076-1090.
92. Bain C.C., Scott C.L., Uronen-Hansson H., Gudjonsson S., Jansson O., Grip O., et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C(hi) monocyte precursors. Mucosal Immunol 2012, 6:498-510.
93. Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
94. Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., Van Rooijen N., et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332:1284-1287.
95. Girgis N.M., Gundra U.M., Ward L.N., Cabrera M., Frevert U., Loke P. Ly6Chigh monocytes become alternatively activated macrophages in Schistosome granulomas with help from CD4+ cells. PLoS Pathog 2014, 10(6):e1004080.
96. Nascimento M., Huang S.C.-C., Smith A., Everts B., Lam W., Bassity E., et al. Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis. PLoS Pathog 2014, [in press].
97. Gundra U.M., Girgis N.M., Ruckerl D., Jenkins S., Ward L.N., Kurtz Z.D., et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014, 123:e110-e122.
98. Rothenberg M.E., Hogan S.P. The eosinophil. Annu Rev Immunol 2006, 24:147-174.
99. Shin E.H., Osada Y., Sagara H., Takatsu K., Kojima S. Involvement of complement and fibronectin in eosinophil-mediated damage to Nippostrongylus brasiliensis larvae. Parasite Immunol 2001, 23:27-37.
100. Hamann K.J., Gleich G.J., Checkel J.L., Loegering D.A., McCall J.W., Barker R.L. In vitro killing of microfilariae of Brugia-Pahangi and Brugia-Malayi by eosinophil granule proteins. J Immunol 1990, 144:3166-3173.
101. Butterworth A.E., Sturrock R.F., Houba V., Mahmoud A., Sher A., Rees P.H. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature 1975, 256:727-729.
102. Rainbird M.A., MacMillan D., Meeusen E. Eosinophil-mediated killing of Haemonchus contortus larvae: effect of eosinophil activation and role of antibody, complement and interleukin-5. Parasite Immunol 1998, 20:93-103.
103. Shin E.H., Osada Y., Chai J.Y., Matsumoto N., Takatsu K., Kojima S. Protective roles of eosinophils in Nippostrongylus brasiliensis infection. Int Arch Allergy Immunol 1997, 114(Suppl 1):45-50.
104. Daly C.M., Mayrhofer G., Dent L.A. Trapping and immobilization of Nippostrongylus brasiliensis larvae at the site of inoculation in primary infections of interleukin-5 transgenic mice. Infect Immun 1999, 67:5315-5323.
105. Knott M.L., Matthaei K.I., Giacomin P.R., Wang H., Foster P.S., Dent L.A. Impaired resistance in early secondary Nippostrongylus brasiliensis infections in mice with defective eosinophilopoeisis. Int J Parasitol 2007, 37:1367-1378.
106. Abraham D., Leon O., Schnyder-Candrian S., Wang C.C., Galioto A.M., Kerepesi L.A., et al. Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae. Infect Immun 2004, 72:810.
107. Martin C., Al-Qaoud K.M., Ungeheuer M.N., Paehle K., Vuong P.N., Bain O., et al. IL-5 is essential for vaccine-induced protection and for resolution of primary infection in murine filariasis. Med Microbiol Immunol 2000, 189:67-74.
108. Le Goff L., Loke P., Ali H.F., Taylor D.W., Allen J.E. Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite. Infect Immun 2000, 68:2513-2517.
109. Babayan S.A., Read A.F., Lawrence R.A., Bain O., Allen J.E. Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy. PLoS Biol 2010, 8:e1000525.
110. Sher A., Coffman R.L., Hieny S., Cheever A.W. Ablation of eosinophil and ige responses with Anti-IL-5 or Anti-IL-4 antibodies fails to affect immunity against Schistosoma-Mansoni in the mouse. J Immunol 1990, 145:3911-3916.
111. Herndon F.J., Kayes S.G. Depletion of eosinophils by anti-Il-5 monoclonal-antibody treatment of mice infected with Trichinella-Spiralis does not alter parasite burden or immunological resistance to reinfection. J Immunol 1992, 149:3642-3647.
112. Betts C.J., Else K.J. Mast cells, eosinophils and antibody-mediated cellular cytotoxicity are not critical in resistance to Trichuris muris. Parasite Immunol 1999, 21:45-52.
113. Korenaga M., Hitoshi Y., Yamaguchi N., Sato Y., Takatsu K., Tada I. The role of interleukin-5 in protective immunity to Strongyloides-Venezuelensis infection in mice. Immunology 1991, 72:502-507.
114. Sasaki O., Sugaya H., Ishida K., Yoshimura K. Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus-Cantonensis in the mouse. Parasite Immunol 1993, 15:349-354.
115. Simons J.E., Rothenberg M.E., Lawrence R.A. Eotaxin-1-regulated eosinophils have a critical role in innate immunity against experimental Brugia malayi infection. Eur J Immunol 2005, 35:189-197.
116. Cadman E.T., Thysse K.A., Bearder S., Cheung A.Y.N., Johnston A.C., Lee J.J., et al. Eosinophils are important for protection, immunoregulation and pathology during infection with nematode microfilariae. PLoS Pathog 2014, 10:e1003988.
117. Ramalingam T., Porte P., Lee J., Rajan T.V. Eosinophils, but not eosinophil peroxidase or major basic protein, are important for host protection in experimental Brugia pahangi infection. Infect Immun 2005, 73:8442-8443.
118. Specht S., Saeftel M., Arndt M., Endl E., Dubben B., Lee N.A., et al. Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect Immun 2006, 74:5236-5243.
119. Padigel U.M., Hess J.A., Lee J.J., Lok J.B., Nolan T.J., Schad G.A., et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007, 196:1844-1851.
120. Piehler D., Stenzel W., Grahnert A., Held J., Richter L., Koehler G., et al. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am J Pathol 2011, 179:733-744.
121. Walsh E.R., Sahu N., Kearley J., Benjamin E., Kang B.H., Humbles A., et al. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med 2008, 205:1285-1292.
122. Fulkerson P.C., Fischetti C.A., Rothenberg M.E. Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am J Pathol 2006, 169:2117-2126.
123. Sabin E.A., Kopf M.A., Pearce E.J. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996, 184:1871-1878.
124. Voehringer D., Reese T.A., Huang X., Shinkai K., Locksley R.M. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med 2006, 203:1435-1446.
125. Fabre V., Beiting D.P., Bliss S.K., Gebreselassie N.G., Gagliardo L.F., Lee N.A., et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol 2009, 182:1577-1583.
126. Gebreselassie N.G., Moorhead A.R., Fabre V., Gagliardo L.F., Lee N.A., Lee J.J., et al. Eosinophils preserve parasitic nematode larvae by regulating local immunity. J Immunol 2012, 188:417-425.
127. Bassett E.G., Baker J.R., de Souza P. A light microscopical study of healing incised dermal wounds in rats, with special reference to eosinophil leucocytes and to the collagenous fibres of the periwound areas. Br J Exp Pathol 1977, 58:581-605.
128. Goh Y.P.S., Henderson N.C., Heredia J.E., Red Eagle A., Odegaard J.I., Lehwald N., et al. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci USA 2013, 110:9914-9919.
129. Heredia J.E., Mukundan L., Chen F.M., Mueller A.A., Deo R.C., Locksley R.M., et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013, 153:376-388.
130. Todd R., Donoff B.R., Chiang T., Chou M.Y., Elovic A., Gallagher G.T., et al. The eosinophil as a cellular source of transforming growth factor-alpha in healing cutaneous wounds. Am J Pathol 1991, 138:1307-1313.
131. Wong D., Donoff R.B., Yang J., Song B.Z., Matossian K., Nagura N., et al. Sequential expression of transforming growth-factor-alpha and factor-beta(1) by eosinophils during cutaneous wound-healing in the hamster. Am J Pathol 1993, 143:130-142.
132. Schultz G., Rotatori D.S., Clark W. Egf and Tgf-alpha in wound-healing and repair. J Cell Biochem 1991, 45:346-352.
133. Birkland T.P., Cheavens M.D., Pincus S.H. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Dermatol Res 1994, 286:312-318.
134. Zagai U., Sköld C.M., Trulson A., Venge P., Lundahl J. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin Exp Immunol 2004, 135:427-433.
135. Wong C.-K., Leung K.M.-L., Qiu H.-N., Chow J.Y.-S., Choi A.O.K., Lam C.W.-K. Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PLoS ONE 2012, 7:e29815.
136. Bouffi C., Rochman M., Zust C.B., Stucke E.M., Kartashov A., Fulkerson P.C., et al. IL-33 markedly activates murine eosinophils by an NF-(B-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J Immunol 2013, 191:4317-4325.
137. Leitch V.D., Strudwick X.L., Matthaei K.I., Dent L.A., Cowin A.J. IL-5-overexpressing mice exhibit eosinophilia and altered wound healing through mechanisms involving prolonged inflammation. Immunol Cell Biol 2009, 87:131-140.
138. Munder M., Eichmann K., Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 1998, 160:5347-5354.
139. Munder M., Choi B.-S., Rogers M., Kropf P. L-arginine deprivation impairs Leishmania major-specific T-cell responses. Eur J Immunol 2009, 39:2161-2172.
140. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., et al. Role of arginine metabolism in immunity and immunopathology. Immunobiology 2008, 212:795-812.
141. Zhu X., Pribis J.P., Rodriguez P.C., Morris S.M., Vodovotz Y., Billiar T.R., et al. The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann Surg 2014, 259:171-178.
142. Morris S.M. Arginine metabolism: boundaries of our knowledge. J Nutr 2007, 137:1602S-1609S.
143. Obata-Ninomiya K., Ishiwata K., Tsutsui H., Nei Y., Yoshikawa S., Kawano Y., et al. The skin is an important bulwark of acquired immunity against intestinal helminths. J Exp Med 2013, 210:2583-2595.
144. Pesce J.T., Ramalingam T.R., Mentink-Kane M.M., Wilson M.S., Kasmi El K.C., Smith A.M., et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009, 5:e1000371.
145. Barron L., Smith A.M., Kasmi El K.C., Qualls J.E., Huang X., Cheever A., et al. Role of arginase 1 from myeloid cells in th2-dominated lung inflammation. PLoS ONE 2013, 8:e61961.
146. Kasmi El K.C., Qualls J.E., Pesce J.T., Smith A.M., Thompson R.W., Henao-Tamayo M., et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 2008, 9:1399-1406.
147. Zaiss D.M., Yang L., Shah P.R., Kobie J.J., Urban J.F., Mosmann T.R. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science 2006, 314:1746.
148. Zaiss D.M.W., van Loosdregt J., Gorlani A., Bekker C.P.J., Gröne A., Sibilia M., et al. Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 2013, 38:275-284.
149. Cliffe L.J., Humphreys N.E., Lane T.E., Potten C.S., Booth C., Grencis R.K. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005, 308:1463-1465.
150. Monticelli L.A., Sonnenberg G.F., Abt M.C., Alenghat T., Ziegler C.G.K., Doering T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054.
151. Burzyn D., Kuswanto W., Kolodin D., Shadrach J.L., Cerletti M., Jang Y., et al. A special population of regulatory T cells potentiates muscle repair. Cell 2013, 155:1282-1295.
152. Jamieson A.M., Pasman L., Yu S., Gamradt P., Homer R.J., Decker T., et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013, 340:1230-1234.
153. Perugorria M.J., Latasa M.U., Nicou A., Cartagena-Lirola H., Castillo J., Goñi S., et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology 2008, 48:1251-1261.
154. Reece J.J., Siracusa M.C., Scott A.L. Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages. Infect Immun 2006, 74:4970-4981.
155. Harris N., Gause W.C. To B or not to B: B cells and the Th2-type immune response to helminths. Trends Immunol 2011, 32:80-88.
156. Palm N.W., Rosenstein R.K., Yu S., Schenten D.D., Florsheim E., Medzhitov R. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013, 39:976-985.
157. Marichal T., Starkl P., Reber L.L., Kalesnikoff J., Oettgen H.C., Tsai M., et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013, 39:963-975.
158. Karp C.L., Murray P.J. Non-canonical alternatives: what a macrophage is 4. J Exp Med 2012, 209:427-431.
159. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., et al. IL-33 reduces the development of atherosclerosis. J Exp Med 2008, 205:339-346.